Information to help you stay the course
First and foremost, we understand that many health authorities, governments and biopharmaceutical companies have shifted their focus to the global pandemic and how to prevent, diagnose and treat COVID-19. However, we can’t dismiss the number of novel therapies currently in development or in the approval process for the multitude of other diseases affecting people worldwide. Utilizing the new guidance from FDA and other regulatory agencies, we are here to help keep your current programs moving forward and can address concerns that may arise.
The COVID-19 Pandemic is driving the rapid need and adoption of virtual trials where patients are treated at their homes instead of going into a clinical site/office/hospital. We are running virtual trials right now by designing a customized virtual trial ecosystem to satisfy both the study and patients' needs.
We are happy to talk with you and help you keep your program on track.
